Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-061162

President sold 100,000 shares at $125.00 ($12,500,000)

  • President acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2020-11-30 Option exercise +50,000 $14.00 $700,000 698,007 D
Novak Rodger President 2020-11-30 Sale −50,000 $125.00 $6,250,000 648,007 D
Novak Rodger President 2020-11-30 Option exercise +50,000 $14.43 $721,500 698,007 D
Novak Rodger President 2020-11-30 Sale −50,000 $125.00 $6,250,000 648,007 D
Derivatives
Novak Rodger President 2020-11-30 Option exercise · Stock Option (Right to Buy) −50,000 61,893 D
Novak Rodger President 2020-11-30 Option exercise · Stock Option (Right to Buy) −50,000 140,315 D
Open-market sales · 100,000 sh · avg $125.00 · $12,500,000
Loading xslF345X03/doc4.xml…